Skip to main content

Table 1 Summarized genotype and clinical phenotype of patients with mutations in FARSA gene

From: Phenylalanyl-tRNA synthetase deficiency caused by biallelic variants in FARSA gene and literature review

Genotype and Clinical phenotype

FARSA subjects

1

2

3

4

5

Σ

P1

P2

P3

P4

P5

P6

P7

P8

P9

P10

Genotype of FARSA gene (variant 1, variant 2)

L391P R404H

F256L N410K

R404C E418D

R295W R295W

F277V F277V

R295W R295W

V356I V356I

R475Q P347L

-

Respiratory system

interstitial lung disease

 

9/10

cholesterol pneumonitis

 

 

  

6/10

pulmonary alveolar proteinosis

   

 

 

  

3/10

cystic lung disease

 

 

     

3/10

digital clubbing

 

 

   

5/10

Growth

failure to thrive

10/10

feeding difficulty/diarrhea

 

 

  

6/10

Liver

hepatomegaly/ hepatosplenomegaly

 

 

8/10

abnormal liver values (blood)

    

6/10

liver steatosis/ hyperechogenicity

 

 

 

 

6/10

Musculature

hypotonia

     

5/10

decreased muscle mass

 

  

     

2/10

abnormal muscle histology

  

       

1/10

Nervous system

neurodevelopmental/ speech delay

 

   

6/10

headache

  

       

1/10

microcephaly

      

 

3/10

brain cysts

 

  

     

2/10

brain calcifications

 

       

2/10

white matter lesions

  

  

 

 

4/10

brain aneurysm

  

     

 

2/10

Skeletal system

pectus carinatum/ excavatum

 

       

2/10

joint hyperflexibility

 

       

2/10

osteopenia

  

      

2/10

Marfan-like syndrome

 

       

2/10

Endocrine system

growth hormone resistance/ deficiency

  

 

     

2/10

hypothyroidism

       

3/10

Dysmorphic features

face/body appearance

       

3/10

Eye

abnormal eye movement

   

      

1/10

Ear

sensorineural hearing loss

    

     

1/10

Cardiovascular system

structural heart/vessel defects

 

 

     

3/10

Immune system

abnormal blood cell counts

       

3/10

IgG deficiency

   

      

1/10

hypoalbuminemia

 

9/10

Chronic inflammation

    

 

5/10

Gastrointestinal tract

hernia

 

        

1/10

Urinary system

vesicoureteral reflux

 

        

1/10

nephrolithiasis

    

     

1/10

hyperphosphaturia

   

      

1/10

tubulopathy

   

     

2/10

proteinuria

         

1/10

Skin

poor wound healing

  

       

1/10

abnormal subcutaneous fat tissue

 

 

      

2/10

  1. 1 (Patient 1, P1), presented here; 2, (Patient 2, P2), Krenke. et al. presented; 3 (Patient 3–5, P3-P5), Schuch et al. presented; 4 (Patient 6–9, P6-P9), Charbit-Henrion et al. Presented; 5 (Patient 10, P10), Kin et al. presented. The dark spot reflects positivity, empty reflects negativity or unknown status